S3758119th CongressWALLET

End Veterans Overdose Act of 2026

Sponsored By: Senator Shaheen, Jeanne [D-NH]

Introduced

Summary

Free, no-prescription opioid overdose rescue meds for eligible veterans and caregivers.

Show full summary
  • Caregiver definition: The bill specifies eligible caregivers as family caregivers in the VA's comprehensive assistance program and caregivers in the VA's general caregiver support program.
  • Privacy limits: The VA may collect only personally identifiable information needed to prescribe these medicines and may use that data only to deliver, evaluate, and improve health care. The VA may not use that data to block employment or as evidence of past or illegal drug use or addiction.
  • Reporting and oversight: Not later than two years after the VA first makes these medicines available, and annually after that, the Secretary must report to Congress on the number of recipients, trends in use, and the feasibility of expanding the authority to immediate family members and to non-VA health providers through which the VA furnishes care.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Free naloxone at VA pharmacies

If enacted, you would be able to get opioid overdose rescue medicine, like naloxone, for free at VA pharmacies if you are a covered veteran or a qualifying caregiver. You would not need a prescription. The VA would give drug-use information with each medicine. The VA would only collect personal data needed to prescribe the medicine and could use it only to deliver, evaluate, and improve health care. That data could not be used to block employment or as evidence of drug use or addiction. The VA would report to Congress within two years after it first offers the medicines and then each year with recipient counts, feasibility assessments on expanding access to immediate family and to non-VA providers that furnish VA care, trends in use, and other recommendations.

Sponsors & CoSponsors

Sponsor

Shaheen, Jeanne [D-NH]

NH • D

Cosponsors

  • Sen. Crapo, Mike [R-ID]

    ID • R

    Sponsored 2/2/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation